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Background: India’s national Expanded Programme on Immu-
nization(EPI) launched in 1978 offers vaccines such as BCG,
DPT, OPV, and measles vaccine free of cost, while pediatrician-
recommended non-EPI vaccines are available for purchase in the
country. On September 1st 1994 the Pediatric Department, Chris-
tianMedical College,Vellore expanded immunization services from
2 afternoons/week into a daily full-time walk-in immunization
clinic offering both EPI and non-EPI vaccines. In this study we ana-
lyze time trends in vaccination provided by this clinic over two
decades.
Methods & Materials: Manually entered records till 1st January
1996 and subsequent computerized clinic records were accessed
for information on vaccine types and doses delivered from 1st
January 1995 to 31st December 2014.
Results: The number of children attending the clinic showed a
>2-fold increase from 31045 in 1995 to 89439 in 2014, averaging
>7000/month and nearly 250/day in 2014. EPI vaccines increased
proportionately for DPT (13313 in 1996 to 30641 doses in 2014),
4-fold for BCG(2650 in 1996 to 11610 in 2014) and over 5-fold for
OPV(10452 in 1996 to 52200 in 2014). Hemophilus inﬂuenzae type
b(Hib) vaccine was made available as a single vaccine from June
1997, as a quadrivalent(DPT-Hib) vaccine from September 1999
and as a pentavalent(DPT-Hepatitis B-Hib) vaccine from December
2002, nearly a decade before pentavalent vaccine provision on the
national programme in 2011. Hib vaccine doses increased 6-fold
from 4420 doses in 1998 to 28415 in 2014, with >15000 doses
administered annually from 2001 and >20000 doses annually from
2008. The proportion of DPT and Hib administered as a combina-
tion vaccine increased from3.7% in 1999 to 92% for DPT and 99% for
Hib in 2014. Number of injections received at each child-visit did
not exceed 2, and the average cost of a visit providing combination
vaccines was kept to <500 INR(<10 USD).
Conclusion: Affordability and ease of access were the keys to
sustained growth in vaccine provision from this private not-for-
proﬁt clinic of a tertiary care centre, and similar strategies can be
used to improve immunization coverage in the country. Hib dis-
ease reduction in our community was documented by us earlier,
attributable to Hib vaccine provision from this clinic.
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Correlation of Interferon-gamma and
Interleukin-28B levels in patients with chronic
hepatitis C viral infection with or without
Schistosoma mansoni coinfection
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Background:Hepatitis C viral infection (HCV)presents a serious
health problem worldwide and is endemic in Egypt. Egypt has the
highest prevalence ofHCV in theworldwith an infection rate of one
in ﬁve individuals. HCV infection in Egypt is usually associatedwith
Schistosoma mansoni coinfection, another endemic disease in Egypt
since the Pharos. Interleukin-28B (IL-28B) and interferon-gamma
(IFN-g) are two of the mostly recognized immunological cytokines
appearing in response to these diseases. The aimof our studywas to
investigate the relationship between IL-28B and endogenous IFN-g
in untreated patients infected with HCV alone and coinfected with
S. mansoni.
Methods & Materials: Serum levels of IFN-g and IL-28B were
measured by ELISA in three groups: 50 untreated patients with
chronic HCV infection (group I), 22 untreated patients with chronic
HCV co-infected with S. mansoni (group II), and 35 healthy control
subjects (group III). All patients were conﬁrmed for HCV RNA pos-
itivity, with viral load quantitated by PCR. Routine liver function
tests were performed for all groups, and diagnosis of S. mansoni
infectionwasbasedon seropositivity for antischistosomal antibody
by Indirect Haemagglutination technique.
Results: We found that serum total protein, albumin levels,
and AST/ALT ratio were higher in HCV patients than in both HCV
co-infected with S. mansoni and control groups (p<0.01). Mean-
while, g-GT levels were higher in HCV patients co-infected with S.
mansoni than HCV alone (p<0.0001). IFN-g and IL-28B levels were
directly correlated to viral load in both HCV and HCV co-infected
with S. mansoni groups (p<0.001). Both serum IFN-g and IL-28B
were signiﬁcantly elevated in both chronic HCV patients and those
co-infected with S. mansoni compared to controls (p<0.0001). Cor-
relation analyses showed that IFN- and IL-28B were positively
correlated in patients with chronic HCV monoinfection (r=0.95,
p<0.0001) and coinfection (r=0.87, p<0.0001) but not in control
group.
Conclusion: In conclusion, our data suggests a strong positive
correlation between IFN- and IL-28B in patients infected with
chronic HCV with or without S. mansoni coinfection. Also, both
cytokines are found to be associated with HCV viral load either
with or without S.mansoni coinfection.
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